Médecins Dr. Brigitte Pellae-Cosset

Alternating radiotherapy and chemotherapy in limited disease small cell lung cancer

DOI: 10.1016/s0167-8140(97)00189-8

A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis

DOI: 10.1016/s0360-3016(97)00254-x

Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience

Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma

DOI: 10.1016/s1278-3218(97)83532-9

Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety

Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer Group

DOI: 10.1002/1097-0142(19951201)76:11<2260::aid-cncr2820761113>3.0.co;2-d

Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results